Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
45.36
+0.54 (1.20%)
At close: Jan 29, 2026, 4:00 PM EST
45.35
-0.01 (-0.02%)
After-hours: Jan 29, 2026, 4:20 PM EST

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $209.36M in the quarter ending September 30, 2025, with 31.42% growth. This brings the company's revenue in the last twelve months to $757.07M, up 26.34% year-over-year. In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth.

Revenue (ttm)
$757.07M
Revenue Growth
+26.34%
P/S Ratio
1.91
Revenue / Employee
$2,120,636
Employees
357
Market Cap
1.43B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024631.45M64.68M11.41%
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition